medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2005, Número 3

<< Anterior Siguiente >>

Rev Inst Nal Enf Resp Mex 2005; 18 (3)


Uso del pericardio bovino tratado con glutaraldehído

Pérez CD, Sotres VA, Jasso VR, Olmos ZJR, Villalba CJ, Santibáñez SJA, Santillán DP

Idioma: Español
Referencias bibliográficas: 46
Paginas: 224-229
Archivo PDF: 61.33 Kb.


RESUMEN

El uso de las prótesis mecánicas y biológicas surgió de la necesidad de reemplazar quirúrgicamente la falta o la falla de un órgano. Las bioprótesis están hechas a partir de tejido autólogo, homólogo y heterólogo. La bioprótesis de pericardio bovino tratada con glutaraldehído es la más estudiada y se utiliza principalmente como bioprótesis cardiaca. Debido a su fácil preparación y uso, este material se ha empleado para reparar defectos herniarios de la pared abdominal, la pared torácica, de diafragma y para sustituir vasos y tráquea; sin embargo, causa reacción de rechazo y tipo cuerpo extraño, los que han sido estudiados ampliamente para evitarlos. Presentamos una revisión de la literatura sobre el uso y estudio de la bioprótesis de pericardio bovino tratado con glutaraldehído.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Holt JP. The normal pericardium. Am J Cardiol 1970;26:455-465.

  2. Elias H, Boyd LJ. Notes on the anatomy, embryology, and histology of the pericardium. II. N Y Med Coll News Notes 1960;2:50-75.

  3. Ishihara T, Ferrans VJ, Jones M, Boyce SW, Kawanami O, Roberts WC. Histologic and ultrastructural features of normal human parietal pericardium. Am J Cardiol 1980;46:744-753.

  4. Santibáñez-Salgado JA. Tratamiento quirúrgico de hernias postincisionales con pericardio de bovino tratado con glutaraldehído (tesis). México, DF: UNAM; 1993.

  5. Santillan-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Thoracoabdominal wall repair with glutaraldehyde-preserved bovine pericardium. J Invest Surg 1996;9:45-55.

  6. Smith DJ Jr, Jones CS, Hull M, Robson MC, Kleinert HE. Bioprostheses in hand surgery. J Surg Res 1986; 41:378-387.

  7. Hellstrom WJ, Reddy S. Application of pericardial graft in the surgical management of Peyronie’s disease. J Urol 2000;163:1445-1447.

  8. Pais VM Jr, Jiang Z, Fung LC. Foreign-body reaction to bovine pericardium: a previously unreported complication of pediatric chordee repair. J Urol 2002;168:702-703.

  9. Olmos-Zúñiga JR, Jasso-Victoria R, Sotres-Vega A, et al. Utilización de pericardio bovino tratado con glutaraldehído liofilizado en la reparación de defectos abdominales en ratas. Cir Gen 1996;18:161-165.

  10. Rey A. Hernioplastía ventral infraumbilical en equino con pericardio de bovino tratado con glutaraldehído. Reporte de un caso. Memorias del Primer Congreso Nacional de Cirugía Veterinaria. México, DF: UNAM;1990.

  11. Reyes F. Hernioplastía ventral en caninos con bioprótesis de pericardio bovino tratado con glutaraldehído (tesis). México, DF: UNAM;1990.

  12. Santillán-Doherty P, Jasso-Victoria R, Sotres-Vega A, et al. Reparación de defectos de pared toracoabdominal de perros con bioprótesis de pericardio bovino. Rev Invest Clin 1995;47:439-449.

  13. Olmos-Zúñiga JR. Estudio funcional y microestructural de bioprótesis de pericardio bovino tratado con glutaraldehído en diafragma de perros (tesis). México, DF: UNAM;1990.

  14. Gallo JI, Artiñano E, Val F, Duran CG. Glutaraldehyde-preserved heterologous pericardium for the repair of diaphragmatic defects: experimental study. J Thorac Cardiovasc Surg 1982;83:905-908.

  15. Boin I de F, Joaquim JL, Leonardi LS. Glutaraldehyde-preserved bovine pericardium for the repair of diaphragmatic defects due to extensive metastatic liver resection. Hepatogastroenterology 2003;50:839-840.

  16. Jasso-Victoria R, Olmos-Zúñiga JR, Arreola-Ramírez JL, Sotres-Vega A, Vanda-Cantón B, Santillán-Doherty P. Reconstrucción del esternón con pericardio bovino tratado con glutaraldehído (PBTG). Estudio experimental. Rev Inst Nal Enf Resp Méx. 1995;8:189-191.

  17. Olmos-Zúñiga JR, Jasso-Victoria R, Sotres-Vega A, et al. Evaluación de la utilidad del pericardio bovino en resecciones pulmonares no anatómicas en perros. Rev Invest Clin 2002;54:334-341.

  18. Binet JP, Planche C, Weiss M. Heterograft replacement of the aortic valve. In: Ionescu MI, Ross DN, Wooler GH, editors. Biological tissue in heart valve replacement. London: Butterworths; 1972.p.515-541.

  19. Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C. Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 1969;58:467-483.

  20. Carpentier A, Deloche A, Relland J, et al. Six-year follow-up of glutaraldehyde-preserved heterografts. With particular reference to the treatment of congenital valve malformations. J Thorac Cardiovasc Surg 1974;68:771-782.

  21. Schoen FJ, Hobson CE. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 1985;16:549-559.

  22. Schoen FJ, Titus JL, Lawrie GM. Autopsy-determined causes of death after cardiac valve replacement. JAMA 1983;249:899-902.

  23. Roberts WC. Factors determining outcome of cardiac valve replacement. Ann Thorac Surg 1979;27:101-103.

  24. Schoen FJ, Fernandez J, Gonzalez-Lavin L, Cernaianu A. Causes of failure and pathological findings in surgically removed Ionescu-Shiley standard bovine pericardial heart valve bioprostheses: emphasis on progressive structural deterioration. Circulation 1987;76:618-627.

  25. Schoen FJ, Levy RJ. Bioprosthetic heart valve failure: pathology and pathogenesis. Cardiol Clin 1984;2:717-739.

  26. Schoen FJ, Tsao JW, Levy RJ. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol 1986;123:134-145.

  27. Fischbein MC, Levy RJ, Ferrans VJ, et al. Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in subcutaneous implantation model system. J Thorac Cardiovasc Surg 1982;83:602-609.

  28. Ferrans VJ, Boyce SW, Billingham ME, Jones M, Ishihara T, Roberts WC. Calcific deposits in porcine bioprostheses: structure and pathogenesis. Am J Cardiol 1980;46:721-734.

  29. Valente M, Bortolotti U, Thiene G. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985;119:12-21.

  30. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart-valve calcification. Lab Invest 1985;52:523-532.

  31. Harasaki H, McMahon J, Richards T, Goldcamp J, Kiraly R, Nose Y. Calcification in cardiovascular implants: degraded cell-related phenomena. Trans Am Soc Artif Intern Organs 1985;31:489-494.

  32. Levy RJ, Schoen FJ, Flowers WB, Staelin ST. Initiation of mineralization in bioprosthetic heart valve: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 pre-incubations. J Biomed Mater Res 1991;25:905-935.

  33. Maranto AR, Schoen FJ. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valve. Circ Res 1988;63:844-848.

  34. Levy RJ, Schoen FJ, Golomb G. Bioprosthetic heart valve calcification: clinical features, pathobiology and prospects for prevention. CRC Crit Rev Biocompat 1986;2:147-187.

  35. Fishbein MC, Levy RJ, Ferrans VJ, et al. Calcification of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. J Thorac Cardiovasc Surg 1982;83:602-609.

  36. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983;113:143-155.

  37. Golomb G, Schoen FJ, Smith MS, Linden J, Dixon M, Levy RJ. The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol 1987;127:122-130.

  38. Vasudev SC, Chandy T, Umasankar MM, Sharma CP. Inhibition of bioprosthesis calcification due to synergistic effect of Fe/Mg ions to polyethylene glycol grafted bovine pericardium. J Biomater Appl 2001;16:93-107.

  39. Golomb G. Controlled release of diphosphonates from synthetic polymers to inhibit calcification. J Biomater Appl 1987;2:266-289.

  40. Chandy T, Mohanty M, John A, et al. Structural studies on bovine bioprosthetic tissues and their in vivo calcification: prevention via drug delivery. Biomaterials 1996;17:577-585.

  41. Webb CL, Schoen FJ, Flowers WE, Alfrey AC, Horton C, Levy RJ. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3 and Ga(NO3)3 in rat subdermal model studies. Am J Pathol 1991;138:971-981.

  42. Fitzgibbons RJ Jr, Greenburg AG, Nyhus LM. Nyhus and condon´s hernia. 5th ed. Philadelphia, USA: Lippincot and Wilkins;1989.

  43. Schwartz DI, Ellis H. Maingot’s abdominal operations. 9th ed. Norwalk, Connecticut, USA: Appleton & Lange;1989.

  44. Skandalakis JE, Gray DW, Mansberger AR, et al. Hernia: surgical anatomy and technique. Singapore: Mc Graw-Hill;1989.

  45. Sher W, Pollack D, Paulides CA, Matsumoto T. Repair of abdominal wall defects: Gore-Tex vs Marlex graft. Am Surg 1980;46:618-623.

  46. Arreola-Ramírez JL. Utilización del pericardio bovino como sustituto de tráquea (tesis). México, DF: UNAM;1990.




2020     |     www.medigraphic.com